Dina Fine Maron, Editor of Health & Medicine at Scientific American, joins Cheddar to discuss some of the biggest changes to science regulations we'll see in 2018. From food labels to nonaddictive cigarettes, people need to be aware of what might affect their everyday lives.
A revamped nutrition label was slated to debut in July of 2018, however the Trump administration is giving companies a longer window. Major companies now have until 2020 and smaller companies have until 2021. The new labels will have more detail on added sugar and calorie count. However, critics say the delay could be a major blow to the public's health.
Plus, the U.S. Food and Drug Administration aims to create a nonaddictive cigarette with lower nicotine levels. It hopes this will help smokers quit. However, the agency opened up the conversation to the public for input which will ellicit some strong views from the tobacco industry.
Clive McCoy, director of tourism for the British Virgin Islands, joined Cheddar to discuss how the territory was relaxing restrictions for travel to resume back to the tropical getaway.
While much of the world remains hunkered down, the band Six60 has been playing to huge crowds in New Zealand, where social distancing isn’t required after the nation stamped out the coronavirus.
The charitable arm of San Francisco-based technology giant Cisco Systems has pledged to invest $100 million over the next decade to help reverse the impact of climate change.
The White House says the U.S. will begin sharing its entire stock of AstraZeneca COVID-19 vaccines with the world once it clears federal safety reviews.
Officials say the European Union is finalizing plans to allow tourists from the United States to travel to the 27-nation bloc this summer.
Jill is joined by Baker Machado this morning to talk about the CDC reinstating the J&J vaccine, a worsening Coronavirus crisis in India, but also, where things are looking a lot better.
Michigan has become the current national hotspot for COVID-19 infections and hospitalizations at a time when more than half the U.S. adult population has been vaccinated and other states have seen the virus diminish substantially.
A U.S. health panel says it’s time to resume use of Johnson & Johnson’s COVID-19 vaccine, despite a very rare risk of blood clots.
A growing coalition of private companies, nonprofits, and the federal government are pushing for a more unified approach towards COVID vaccination credentialing.
World leaders have joined President Joe Biden at a virtual climate summit to share their stories about how nations can break free of climate-damaging fossil fuels.
